News in Brief

IFF Health builds transparency and ingredient value with Non-GMO status

By Nikki Hancocks contact

- Last updated on GMT

Getty | Nodar Chernishev
Getty | Nodar Chernishev

Related tags: plant based, extracts, Verification

Global health ingredient manufacturer IFF Health has received Non-GMO Project Verified certification for its Go-Less Men pumpkin seed extract for healthy bladder function, as the firm works to build full transparency.

The third-party verification confirms that the ingredient has been evaluated by an independent party for compliance with industry standards.

Go-Less Men is based on bioactive components in pumpkin seeds (Cucurbita pepo​ L.), a plant used by Native Americans to facilitate the passage of urine and an integral part of European herbal medicine since 1539.

Clinical studies have revealed that pumpkin seed extract can help support improved urinary flow rate and voiding time​, and reduce residual urine volume in men suffering from benign prostatic hyperplasia (BPH).

Non-GMO is a fast-growing claim in the global food industry. Moran Werner Saido, Product Manager for IFF Health, says a key factor driving the growth is the increasing consumer awareness of the sources of ingredients and increased interest in all-natural ingredients.

“This certification reflects IFF’s commitment to develop the highest quality ingredients with full transparency and add value to our customer’s products,” ​says Saido. “Go-Less Men is supported by science, non-allergenic and has been shown to support the maintenance of a healthy bladder and prostate. It also is available in pharmaceutical grade.”

Go-Less Men is sourced from 100% European-grown pumpkin. It is manufactured using a proprietary decontamination procedure resulting in an oil-free pumpkin seed extract with ensured increased stability, purity and solubility. The process also eliminates susceptibility to rancidity.

In a recent clinical study​, Go-Less Men demonstrated a capacity to lower urinary symptom frequency and severity in men with benign prostate hyperplasia (BPH). Specifically, the results showed that 500mg taken daily for 12 weeks provided statistically significant reductions in symptoms based on the total International Prostate Symptom Score (IPSS), and of all BPH related symptoms, with 30% of men reporting improvement of symptoms from “moderate/severe” to “mild.”

Related news

Related products

show more

cognitaven® boosts cognitive performance

cognitaven® boosts cognitive performance

Anklam Extrakt GmbH | 13-Jul-2020 | Clinical Study

Within the course of a randomised, double-blind, placebo-controlled study, the acute and chronic effects of green oat (Avena sativa) herb extract on cognitive...

Related suppliers

Follow us

Products

View more

Webinars